Obesity Clinical Trial
Official title:
WorkStation Pilot Study
NCT number | NCT01587092 |
Other study ID # | PBRC 12015 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 2012 |
Est. completion date | February 2013 |
Verified date | September 2022 |
Source | Pennington Biomedical Research Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a pilot study to assess the feasibility of using treadmill desks (Workstations) within a Louisiana office workplace and to determine the effects of walking while working in overweight or obese, sedentary individuals.
Status | Completed |
Enrollment | 41 |
Est. completion date | February 2013 |
Est. primary completion date | February 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Males or females - BMI = 25 kg/m2 - Willing to give informed consent - Willing to accept randomization to group assignment and willing to follow the protocol for the group to which they have been assigned - Willing to maintain fulltime employment at the company for the next 6 months - Willing to receive frequent contacts and communication from study staff over the next 6 months Exclusion Criteria: - Current participation in other Pennington Biomedical research studies - BMI < 25 kg/m2 - Type 1 diabetes - Average step count of = 7,500 steps/day - Self-reporting exercising > 20 minutes on 3 or more days/wk, within the past 6 months - Unable to walk 45 minutes continuously without taking a rest - Unable to walk without the use of an assistive device, such as a cane or walker - Have had a cardiovascular event (stroke or heart attack) in the past 6 months - Have a pacemaker or any other internal electrical medical device - Have been diagnosed with Schizophrenia or bipolar disorder - Have any condition that would limit participation in a physical activity program - Women who are pregnant, have been pregnant in the last 6 months, or are breastfeeding - Actively participating in a weight loss program - Plan to move out of the study area within the next 6 months or plan to be away from work for more than 4 weeks in the next 6 months - Have another member of household participating in the study - Have any condition, which, in the opinion of the investigator would impede competence or compliance or possibly hinder completion of the study |
Country | Name | City | State |
---|---|---|---|
United States | Pennington Biomedical Research Center | Baton Rouge | Louisiana |
Lead Sponsor | Collaborator |
---|---|
Pennington Biomedical Research Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Waist | Waist circumference will decrease in workers assigned to the WorkStation working condition relative to the usual working condition. | 6 months | |
Secondary | Weight Assessments | Weight will improve in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. | 6 months | |
Secondary | Body Fat Percent | Body fat percent will improve in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. | 6 months | |
Secondary | Accelerometry | Participants' activity level measured by the accelerometer will increase in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. | 6 months | |
Secondary | Gait Speed | Participants' gait speed will improve in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. | 6 months | |
Secondary | Stress | Participants' stress level will decrease in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. | 6 months | |
Secondary | Fatigue | Participants' fatigue level will decrease in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. | 6 months | |
Secondary | Quality of life Questionnaire | Participants' quality of life will improve in workers assigned to the WorkStation Group relative to the Usual Working Condition Group. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |